Nanomedicine Global Market Report 2025

Description

Nanomedicine involves the application of nanotechnology in the field of medicine. It encompasses substances with sizes ranging from 1 to 100 nanometers, designed to precisely target tumor cells or critical immune cells. Nanomedicine serves as a crucial tool for personalized, targeted, and regenerative medicine, facilitating the delivery of enhanced new drugs, treatments, and implantable devices to both clinicians and patients.

The primary types of nanomedicine include nanoparticles, nanoshells, nanotubes, nanodevices, and others. Nanoparticles, specifically ultrafine particles typically between 1 and 100 nanometers in diameter, are commonly used in the production of medicines and drugs. Nanomedicine operates across different modalities such as diagnostics and treatments, finding applications in clinical oncology, infectious diseases, clinical cardiology, orthopedics, and other medical fields.

The nanomedicine market research report is one of a series of new reports from The Business Research Company that provides nanomedicine market statistics, including nanomedicine industry global market size, regional shares, competitors with a nanomedicine market share, detailed nanomedicine market segments, market trends and opportunities, and any further data you may need to thrive in the nanomedicine industry. This nanomedicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The nanomedicine market size has grown rapidly in recent years. It will grow from $331.61 billion in 2024 to $379.24 billion in 2025 at a compound annual growth rate (CAGR) of 14.4%. The growth in the historic period can be attributed to increased understanding of molecular biology, growing incidence of chronic diseases, demand for targeted drug delivery systems, expansion of nanoparticle imaging technologies, growing aging population.

The nanomedicine market size is expected to see rapid growth in the next few years. It will grow to $690.96 billion in 2029 at a compound annual growth rate (CAGR) of 16.2%. The growth in the forecast period can be attributed to continued growth in nanotechnology research, rising investments in nanomedicine R&D, increasing focus on personalized medicine, expanding applications of nanomedicine in cancer treatment, integration of nanomedicine in infectious disease therapeutics. Major trends in the forecast period include development of multifunctional nanoparticles for therapeutics and imaging, emphasis on nanoparticle-based diagnostics and imaging agents, application of nanomedicine in regenerative medicine, growing use of nanomedicine in targeted therapy for neurological disorders, collaboration and partnerships in nanomedicine research and commercialization.

The anticipated increase in the prevalence of complex and chronic diseases worldwide is expected to contribute to the growth of the nanomedicine market in the forecast period. Nanomedicine is becoming increasingly integral in treating chronic conditions such as cardiovascular disorders, diabetes, cancer, and dementia, facilitating the rapid metabolism of drugs within the body. Notably, Alzheimer's Disease International reports that over 50 million people globally suffer from dementia, a number projected to double every 20 years, reaching 80 million by 2030 and 152 million by 2050. The global cancer burden is also predicted to escalate to 28.4 million new cases in 2040. The escalating burden of chronic diseases is poised to drive demand for effective therapeutic treatments based on nanomedicine, thereby fostering the growth of the nanomedicine market.

The growing demand for personalized medicine is expected to propel the nanomedicine market's growth. Personalized medicine, an innovative approach tailoring medical decisions and interventions to individual patients, holds the promise of improving outcomes and treatment efficacy through cutting-edge technology. Reports from October 2022 indicate more than 75,000 genetic testing products and 300 personalized medicines. This increasing demand for personalized medicine is a key driver behind the growth of the nanomedicine market.

Major players in the nanomedicine market are concentrating on innovative products, such as the dynapro zetastar, to enhance their market presence. This advanced instrument enables simultaneous measurements of dynamic and static light scattering, as well as dynamic and electrophoretic light scattering (DLS/SLS/ELS). For instance, Waters Corporation, a US-based analytical laboratory instruments and equipment company, launched the dynapro zetastar for nanoparticle analysis in September 2023. The instrument aids in the precise development of complex biologics by combining multiple light scattering techniques, offering adaptive data capture, automatic data quality assessment, and increased sensitivity and speed of measurements while using minimal sample volumes. The unique flow cell design allows connection to an autosampler, significantly enhancing laboratory productivity and efficiency by enabling unattended measurements for extended periods.

Innovative technologies, such as optical technology, are being employed by major companies in the nanomedicine market to drive revenues. Corning Incorporated, a US-based technology company, introduced corning videodrop in September 2023-an optical technique measuring the size and concentration of nanoparticles using interferometric microscopy. Videodrop is reliable, quick, and easy to use, with a label-free sample preparation process. The user-friendly software interface ensures smooth operation, and the method allows the quantification of concentration and size distribution without labeling. Viral vectors, including lentivirus, retrovirus, adenovirus, and extracellular vesicles (EVs), within the diameter range of 80-500 nanometers, can be physically titrated using this approach. The Videodrop technique serves as an effective in-process control during the purification process.

In November 2023, Celgene, a US-based integrated biopharmaceutical company dedicated to discovering and developing innovative therapies, acquired a stake in Nano Precision Medical for an undisclosed amount. This acquisition enhances Celgene's position in the nanomedicine market, enabling it to compete more effectively with other pharmaceutical companies that are also investing in innovative drug delivery solutions. Nano Precision Medical, also based in the US, specializes in producing miniaturized, subdermal drug implants using its proprietary NanoPortal technology.

Major companies operating in the nanomedicine market include Pfizer Inc., Ablynx NV, Amgen Inc., Arrowhead Research Inc., Bio-Gate AG, Celgene Corporation, F. Hoffmann-La Roche AG, GE Healthcare, Gilead Sciences Inc., Merck AG, Nanospectra Biosciences, Nanotherapeutics Inc., NanoViricides Inc, Novartis AG, Sanofi S. A., Abraxis Bioscience Inc., Alnylam Pharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., AuraSense Therapeutics LLC, BIND Therapeutics Inc., Camurus AB, Cerulean Pharma Inc., CytImmune Sciences, Fujifilm Holdings, Nanobiosym Inc., Nanobiotix SA, Nanogen Inc., Nanoparticle BioChem Inc., Nanospective Inc., Nanosphere Health Sciences Inc., Nanosys Inc., PerkinElmer Inc., Selecta Biosciences Inc.

North America was the largest region in the nanomedicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nanomedicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the nanomedicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The nanomedicine market consists of sales of gold, silica, iron oxide, polymeric, liposomes, and micelles. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Nanomedicine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on nanomedicine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for nanomedicine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The nanomedicine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Nanoparticles; Nanoshells; Nanotubes; Nanodevices; Other Types
2) By Modality: Diagnostics; Treatments
3) By Application: Clinical Oncology; Infectious Diseases; Clinical Cardiology; Orthopedics; Other Applications
Subsegments:
1) By Nanoparticles: Lipid-Based Nanoparticles; Polymeric Nanoparticles; Metallic Nanoparticles; Ceramic Nanoparticles
2) By Nanoshells: Gold Nanoshells; Silver Nanoshells; Silica Nanoshells
3) By Nanotubes: Carbon Nanotubes (CNTs); Polymer Nanotubes
4) By Nanodevices: Nanosensors; Nanorobots; Nanoscale Imaging Devices
5) By Other Types: Dendrimers; Quantum Dots; Nanocarriers
Companies Mentioned: Pfizer Inc.; Ablynx NV; Amgen Inc.; Arrowhead Research Inc.; Bio-Gate AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r21835

1. Executive Summary

2. Nanomedicine Market Characteristics

3. Nanomedicine Market Trends And Strategies

4. Nanomedicine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Nanomedicine Growth Analysis And Strategic Analysis Framework

5.1. Global Nanomedicine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Nanomedicine Market Growth Rate Analysis
5.4. Global Nanomedicine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Nanomedicine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Nanomedicine Total Addressable Market (TAM)

6. Nanomedicine Market Segmentation

6.1. Global Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Nanoparticles
Nanoshells
Nanotubes
Nanodevices
Other Types
6.2. Global Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Diagnostics
Treatments
6.3. Global Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Clinical Oncology
Infectious Diseases
Clinical Cardiology
Orthopedics
Other Applications
6.4. Global Nanomedicine Market, Sub-Segmentation Of Nanoparticles, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Lipid-Based Nanoparticles
Polymeric Nanoparticles
Metallic Nanoparticles
Ceramic Nanoparticles
6.5. Global Nanomedicine Market, Sub-Segmentation Of Nanoshells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Gold Nanoshells
Silver Nanoshells
Silica Nanoshells
6.6. Global Nanomedicine Market, Sub-Segmentation Of Nanotubes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Carbon Nanotubes (CNTs)
Polymer Nanotubes
6.7. Global Nanomedicine Market, Sub-Segmentation Of Nanodevices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Nanosensors
Nanorobots
Nanoscale Imaging Devices
6.8. Global Nanomedicine Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Dendrimers
Quantum Dots
Nanocarriers

7. Nanomedicine Market Regional And Country Analysis

7.1. Global Nanomedicine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Nanomedicine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Nanomedicine Market

8.1. Asia-Pacific Nanomedicine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Nanomedicine Market

9.1. China Nanomedicine Market Overview
9.2. China Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Nanomedicine Market

10.1. India Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Nanomedicine Market

11.1. Japan Nanomedicine Market Overview
11.2. Japan Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Nanomedicine Market

12.1. Australia Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Nanomedicine Market

13.1. Indonesia Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Nanomedicine Market

14.1. South Korea Nanomedicine Market Overview
14.2. South Korea Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Nanomedicine Market

15.1. Western Europe Nanomedicine Market Overview
15.2. Western Europe Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Nanomedicine Market

16.1. UK Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Nanomedicine Market

17.1. Germany Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Nanomedicine Market

18.1. France Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Nanomedicine Market

19.1. Italy Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Nanomedicine Market

20.1. Spain Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Nanomedicine Market

21.1. Eastern Europe Nanomedicine Market Overview
21.2. Eastern Europe Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Nanomedicine Market

22.1. Russia Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Nanomedicine Market

23.1. North America Nanomedicine Market Overview
23.2. North America Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Nanomedicine Market

24.1. USA Nanomedicine Market Overview
24.2. USA Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Nanomedicine Market

25.1. Canada Nanomedicine Market Overview
25.2. Canada Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Nanomedicine Market

26.1. South America Nanomedicine Market Overview
26.2. South America Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Nanomedicine Market

27.1. Brazil Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Nanomedicine Market

28.1. Middle East Nanomedicine Market Overview
28.2. Middle East Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Nanomedicine Market

29.1. Africa Nanomedicine Market Overview
29.2. Africa Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Nanomedicine Market Competitive Landscape And Company Profiles

30.1. Nanomedicine Market Competitive Landscape
30.2. Nanomedicine Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Ablynx NV Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Arrowhead Research Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Bio-Gate AG Overview, Products and Services, Strategy and Financial Analysis

31. Nanomedicine Market Other Major And Innovative Companies

31.1. Celgene Corporation
31.2. F. Hoffmann-La Roche AG
31.3. GE Healthcare
31.4. Gilead Sciences Inc.
31.5. Merck AG
31.6. Nanospectra Biosciences
31.7. Nanotherapeutics Inc.
31.8. NanoViricides Inc
31.9. Novartis AG
31.10. Sanofi S. A.
31.11. Abraxis Bioscience Inc.
31.12. Alnylam Pharmaceuticals Inc.
31.13. Arrowhead Pharmaceuticals Inc.
31.14. AuraSense Therapeutics LLC
31.15. BIND Therapeutics Inc.

32. Global Nanomedicine Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Nanomedicine Market

34. Recent Developments In The Nanomedicine Market

35. Nanomedicine Market High Potential Countries, Segments and Strategies

35.1 Nanomedicine Market In 2029 - Countries Offering Most New Opportunities
35.2 Nanomedicine Market In 2029 - Segments Offering Most New Opportunities
35.3 Nanomedicine Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer